Skip to content
StockMarketAgent
Direct answer
Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation. Fair value range: low $172, high $303, with mid-point at $237.
Stock analysis

CRM Salesforce Inc. fair value $237–$303

CRM
By StockMarketAgent.AI team· supervised by
Analizzato: 2026-05-09Prossimo aggiornamento: 2026-08-09Methodology v2.4Archetype: Mature compounderNYSE · Information Technology
View archive
Prezzo
$181.82
▲ +55.13 (+30.32%)
Valore equo
$237
$237–$303
Valutazione
Acquisto forte
confidence 88/100
Potenziale rialzo
+30.3%
upside to fair value
Margine di Sicurezza
$201.41
buy below · 15%
Capitalizzazione
$148.7B
P/E fwd 12.2
Fallback in ingleseIT
Mostrando la fonte in inglese mentre traduciamo
Questo report non è ancora stato tradotto. Aggiorna tra qualche minuto una volta che la coda di traduzione avrà recuperato.

§1 Sintesi

  • Transitioning to mature compounder focused on margin expansion and capital return.
  • Exceptional FCF supports aggressive share repurchases.
  • Market over-penalizing top-line fade; under-pricing cash economics.
  • Key risk is a return to undisciplined M&A or high SBC dilution.
Fair value
$237
Margin of safety
+23.3%
Confidence
88/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$181.82Price
FV $236.95
High $303.18

Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation.

  • High switching costs within core
    High switching costs within core enterprise ecosystem
  • Deep integration of multi-cloud CRM
    Deep integration of multi-cloud CRM software
  • Cycle upside
    AI-driven product cycles reignite enterprise IT software spending.

§2 Scenario ribassista

A sustained macroeconomic downturn coupled with deep CRM saturation tests the model. If revenue growthRevenue growthYear-over-year change in revenue, expressed as a percentage. The starting point for any forward-earnings model and the lens through which scale, mix, and pricing power become visible. compresses below 5% and SBCStock-based compensationThe fair-value cost of equity awards (options, RSUs, performance shares) granted to employees. A real economic expense even though it is non-cash. remains elevated, true per-share value erodes despite optical cash generation.

Come questa tesi può fallire

Growth Stagnation

20%· Medium

Core software markets saturate entirely, permanently capping top-line growth below 5%.

FV impact
-27%

M&A Relapse

15%· Low

Management abandons disciplined capital allocation, executing large dilutive acquisitions.

FV impact
-35%

AI Displacement

10%· Low

Agentforce fails to gain traction; nimble AI startups displace core service workflows.

FV impact
-20%
Segnali di allerta precoce da monitorare
MetricaAttualeSoglia di attivazione
Revenue growth drops below 7% over two consecutive quarters.MonitorDeterioration versus the report thesis
Operating margins stall or compress below 30% target.MonitorDeterioration versus the report thesis
Share repurchases halted in favor of large-scale M&A.MonitorDeterioration versus the report thesis
Agentforce adoption rates disappoint internal targets.MonitorDeterioration versus the report thesis
SBC continues to consume outsized portion of operating cash flow.MonitorDeterioration versus the report thesis

§3 Storia finanziaria

Conto economico — ultimi sei periodi
VoceT−0T−1T−2T−3T−4CAGR
Periodo2022-01-312023-01-312024-01-312025-01-312026-01-31Trend
Ricavi$26.49B$31.35B$34.86B$37.90B$41.53B+11.9%
Utile lordo$19.47B$22.99B$26.32B$29.25B$32.26B+13.5%
Reddito operativo$548.0M$1.86B$6.00B$7.67B$8.92B+100.8%
Utile netto$1.44B$208.0M$4.14B$6.20B$7.46B+50.7%
EPS (diluito)$1.48$0.21$4.20$6.36$7.80+51.5%
EBITDA$3.85B$5.64B$9.96B$11.14B$12.55B+34.4%
R&S$4.47B$5.06B$4.91B$5.49B$5.99B+7.6%
SG&A$14.45B$16.08B$14.52B$15.19B$16.35B+3.1%

Punteggi di qualità

Piotroski F-score
7 / 9
Composito qualità 0–9
Altman Z-score
2.49
Rischio di fallimento (>3 sicuro)
Beneish M-score
-2.66
Rischio di manipolazione degli utili
OCF / Utile netto
2.01×
>1 indica alta qualità degli utili
Soglia di qualità contabile
Pass
Soglia corretta per settore
ROIC
9.2%
Rendimento del capitale investito
Sezione 3

Numbers analysis

Allocazione del capitale

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Abbonati individuali — da §4 in poi11 sezioni in più

Leggi l'analisi completa — 11 sezioni in più.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Report completo per ogni ticker coperto
24 mesi di archivio rating
Briefing della watchlist + avvisi di variazione del rating
Esportazione PDF + DOCX in qualsiasi lingua
Inizia la prova gratuita
Annulla in qualsiasi momento.
FAQ

CRM — frequently asked questions

  1. Based on our latest analysis, CRM looks meaningfully undervalued. The current price is $182 versus a composite fair-value midpoint of $237 (range $172–$303), which implies roughly 30.3% upside to the midpoint.
Related coverage

Names readers of CRM also follow

Same archetype: mature-compounder
Same sector: Information Technology